Could your baby be smarter? US startup promises higher IQs in embryos for a hefty price

Heliospect Genomics, a U.S. startup, offers wealthy couples embryo screening for IQ and other traits, costing up to $50,000. This service raises ethical concerns about promoting "superior" genetics and the implications of genetic enhancement. Critics warn of potential societal inequalities, while debates surrounding the use of genetic data intensify. The company claims compliance with applicable laws, yet experts call for public engagement on the moral implications of such technology.